IRENA CULIC: Open Payments
NPI 1023308269 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 114 payments from 18 companies in 2025. Trend: 2023 $3,953 · 2024 $2,975 · 2025 $2,253
Food & beverage: $2,186Education: $67
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $325 |
| ABBVIE INC. | 19 | $309 |
| PFIZER INC. | 10 | $266 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $214 |
| E.R. Squibb & Sons, L.L.C. | 20 | $209 |
| Amgen Inc. | 10 | $199 |
| UCB, Inc. | 9 | $161 |
| Janssen Biotech, Inc. | 4 | $128 |
| Lilly USA, LLC | 4 | $100 |
| GENZYME CORPORATION | 2 | $67 |
Products named: CIBINQO, SKYRIZI, Sotyktu, OTEZLA, Rhapsido, Bimzelx, COSENTYX, TREMFYA.
Industry payments across DC — which companies pay providers there.
